Test Bank for Lippincott Pharmacology Illustrated Reviews 8th Edition by Karen Whalen | All Chapters 1-48 | Complete Guide A+

,Plusbay.Plus

,Plusbay.Plus

, 3. The V VV V VVV nurse is VVVVVVV V VV V VVV teaching a patient V VV V VVV VVVVVVV V VV V VVV who will be discharged V VV V VVV VVVVVVV VVVVVVV V VV V VVV home with a VVVVVVV VVVVVVV VVVV




VVV prescription for an enteric- V VV V VVV VVVVVVV VVVVVVV V VV V VVV coated V VV V VVV tablet. V VV V VVV Which V VV V VVV statement V VV V VVV by the V VV V VVV V VV V VVV patient V V V




V V V V indicates V VV V VVV understanding V VV V VVV of V VV V VVV the V VV V VVV teaching?
a. I may crush the tablet
VVVVVVV V VV V VVV V VV V VVV V VV V VVV V VV V VVV and V VV V VVV put V VV V VVV it V VV V VVV in applesauce to improve absorption.
VVVVVVV V VV V VVV V VV V VVV V VV V VVV




b. I V VV V VVV should V VV V VVV consume V VV V VVV acidic V VV V VVV foods to VVVVVVV V VV V VVV enhance absorption V VV V VVV V VV V VVV of this medication.
V VV V VVV V VV V VVV




c. I should V VV V VVV V VV V VVV expect V VV V VVV a V VV V VVV delay V VV V VVV in V VV V VVV onset V VV V VVV of V VV V VVV the V VV V VVV drugs V VV V VVV effects V VV V VVV after V VV V




taking the
VVV V VV V VVV V VV V VVV tablet.
d. I should take this medication
VVVVVVV V VV V VVV V VV V VVV V VV V VVV V VV V VVV with high-fat VVVVVVV V VV V VVV foods to VVVVVVV V VV V




improve its action. ANS: C
VVV V VV V VVV V VV V VVV V VV V VVV V VV V VVV




Enteric-coated V VV V VVV tablets V VV V VVV resist V VV V VVV disintegration V VV V VVV in V VV V VVV the V VV V VVV acidic V VV V VVV environment V VV V VVV of V VV V VVV the V VV




V VVV stomach V VV V VVV and V VV V VVV disintegrate when they reach the small VVVVVVV V VV V VVV V VV V VVV V VV V VVV VVVVVVV V VV V VVV intestine. There V VV V VVV V VV V VVV is V VV V




VVV usually V VV V VVV some V VV V VVV delay in onset V VV V VVV V VV V VVV V VV V VVV of V VV V VVV actions V VV V VVV after V VV V VVV taking V VV V VVV these V VV V VVV medications. V VV V




VVV Enteric-coated V VV V VVV tablets V VV V VVV should V VV V VVV not V VV V VVV be V VV V VVV crushed V VV V VVV or V VV V VVV chewed, V VV V VVV which V VV V VVV would V VV V




VVV alter the time and VVVVVVV VVVVVVV V VV V VVV V VV V VVV location of absorption. VVVVVVV VVVVVVV V VV V VVV Acidic foods will not V VV V VVV V VV V VVV VVVVVVV V VV V VVV enhance the V VV V VVV V VV V




VVV absorption V VV V VVV of V VV V VVV the V VV V VVV medication. V VV V VVV The V VV V VVV patient V VV V VVV should V VV V VVV not V VV V VVV to V VV V VVV eat V VV V VVV high-fat V VV V




VVV food V VV V VVV before V VV V VVV ingesting V VV V VVV an V VV V VVV enteric-coated V VV V VVV tablet, V VV V VVV because V VV V VVVhigh-fat V VV V VVV foods V VV V




VVV decrease V VV V VVV the V VV V VVV absorption V VV V VVV rate.

DIF: COGNITIVE LEVEL: VVVVVVV V VV V VVV V VV V VVV Applying V VV V VVV (Application) V VV V VVV REF: V




VV V VVV dm V VV V VVV 3 V VV V VVV TOP: V VV V VVV NURSING V VV V VVV PROCESS: V VV V VVV Nursing V VV V




VVV Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological
VVVVVVV VVVVVVV VVVVVVV VVVVVVV V VV V VVV and V VV V VVV Parenteral Therapies VVVVVVV




4. A V VV V VVV patient V VV V VVV who V VV V VVV is V VV V VVV newly V VV V VVV diagnosed V VV V VVV with V VV V VVV type V VV V VVV 1 V VV V VVV diabetes V VV V VVVmellitus V VV V




VVV asks V VV V VVV why V VV V VVV insulin V VV V VVV must V VV V VVV be V VV V VVV given by subcutaneous injectionVVVVVVV VVVVVVV VVVVVVV V VV V VVV instead V VV V VVV of V VV V VVV by VVVV




VVV mouth. The nurse will explain V VV V VVV VVVVVVV VVVVVVV V
V
VVV
V
V V VV V VVV that V VV V VVV this is because VVVVVVV VVVVVVV




a. absorption is VVV V VVV V VV V VVV diminished V VV V VVV by the first-pass effects in the liver.
VVVVVVV V VV V VVV V VV V VVV V VV V VVV VVVVVVV V VV V VVV




b. absorption is V VV V VVV V VV V VVV faster when insulin is given subcutaneously.
VVVVVVV V VV V VVV VVV V VVV VVVVVVV V VV V VVV




c. digestive enzymes in the gastrointestinal tract VVVVVVV VVVVVVV V VV V VVV VVV V VVV VVVVVVV V VV V V V V prevent V V V V VV V absorption.
d. the oral form is VVVVVVV VVVVVVV V
V
VVV
V
V V VV V VVV less V VV V VVV predictable with more VVVVVVV V VV V VVV V VV V




VVV adverse effects. V VV V VVV V VV V VVV ANS: V VV V VVV C
Insulin, V VV V VVV growth hormones, V VV V VVV V VV V VVV and V VV V VVV other protein-based VVVVVVV V VV V VVV drugs are destroyed V VV V VVV V VV V VVV V VV V VVV in the V VV V VVV V




VV V VVVsmall intestine by VVVVVVV V VV V VVV V VV V VVV digestive V VV V VVV enzymes V VV V VVV and V VV V VVV must V VV V VVV be V VV V VVV given V VV V VVV parenterally. V VV V




VVV Because V VV V VVV insulin V VV V VVV is V VV V VVV destroyed V VV V VVV by V VV V VVV digestive V VV V VVV enzymes, V VV V VVV it V VV V VVV would V VV V VVV not V VV V VVV make V VV V




VVV it V VV V VVV to V VV V VVV the liver for metabolism
V VV V VVV VVVVVVV VVVVVVV V VV V VVV with a first-pass VVVVVVV V VV V VVV V VV V VVV effect. Subcutaneous VVVVVVV V VV V VVV tissue V VV V




VVV has V VV V VVV fewer blood V VV V VVV V VV V VVV vessels, V VV V VVV so V VV V VVV absorption V VV V VVV is V VV V VVV slower in V VV V VVV V VV V VVV such V VV V VVV tissue. V VV V VVV Insulin V




Page 2 of 507 V V V




Plusbay.Plus